Brief: Amplia Therapeutics Announces FDA Clearance Of IND For Pancreatic Cancer Trial In US
Jan 18 (Reuters) - Amplia Therapeutics Ltd ATX.AX :
* FDA CLEARANCE OF AMPLIA'S IND FOR PANCREATIC CANCER TRIAL
IN US
Source text for Eikon: ID:nASX151FjF
Further company coverage: ATX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amplia Therapeutics
See all newsBrief: Amplia Therapeutics Signs Collaboration And Supply Agreement With Lilly
Australia's Amplia rises to 4-month high on Eli Lilly cancer drug trial collaboration
Brief: Amplia Therapeutics Says Warwick Tong Will Retire As Board Chairman
Brief: Amplia Therapeutics Reports Four Additional Complete Responses And Improved Overall Survival Data In Accent Pancreatic Cancer Trial
Brief: Amplia Therapeutics Requests Trading Halt Pending Clinical Trial Results Announcement